Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C

Published:2012-10-22 Issue:4 Volume:20 Page:e90-e95
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Borroni G.¹,Cazzaniga M.²,Andreoletti M.³,Ceriani R.⁴,Guerzoni P.⁵,Omazzi B.⁶,Pich M. G. L.⁴,Prada A.⁶,Spinzi G.⁷,Terreni N.⁷,Salerno F.²

Affiliation:

1. Unità Organizzativa Alcoldipendenze, ASL Provincia di Milano 1, Abbiategrasso, Milan; Milan Italy

2. Dipartimento di Medicina Interna; Università degli Studi; IRCCS Policlinico S. Donato; Milan Italy

3. Unità Operativa di Medicina; Ospedale A. Manzoni; Lecco Italy

4. Unità Operativa di Medicina Generale ed Epatologia; IRCCS Istituto Clinico Humanitas; Rozzano Italy

5. Unità Operativa di Gastroenterologia; Ospedale di Varese; Varese Italy

6. Unità Operativa di Gastroenterologia; Azienda Ospedaliera G. Salvini; Rho Italy

7. Unità Operativa di Gastroenterologia; Ospedale Valduce; Como Italy

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12015/fullpdf

Reference28 articles.

1. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002;Armstrong;Ann Intern Med,2006

2. Chronic hepatitis C: an age wave of disease burden;McHutchinson;Am J Manag Care,2005

3. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy;Guadagnino;Hepatology,1997

4. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases;Sagnelli;J Med Virol,2005

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial;Manns;Lancet,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose;Gut and Liver;2020-11-15

2. HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIR;Arquivos de Gastroenterologia;2020-02

3. Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy;Hepatitis Monthly;2015-09-01

4. Telaprevir enhances ribavirin-induced anaemia through renal function impairment;Antiviral Therapy;2015

5. Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score;Journal of Viral Hepatitis;2014-02-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3